"Risk factors in the medical history of pregnant women undergoing congenital heart defect prenatal screening"@en . . . . "congenital heart defect; fetal echocardiography; risk factor"@en . "RIV/00843989:_____/11:00101855!RIV12-MZ0-00843989" . . "Hodnocen\u00ED v\u00FDskytu v\u00FDznamn\u00FDch vrozen\u00FDch srde\u010Dn\u00EDch vad (VSV) v regionu Moravskoslezsk\u00E9ho (MS) kraje, \u00FAsp\u011B\u0161nost jejich prenat\u00E1ln\u00ED detekce a p\u0159edstaven\u00ED fet\u00E1ln\u00ED echokardiografie jako screeningov\u00E9ho vy\u0161et\u0159en\u00ED. Zkoum\u00E1n\u00ED v\u00FDskytu rizikov\u00FDch faktor\u016F v anamn\u00E9ze a jejich vliv na vznik srde\u010Dn\u00ED vady. Pl\u00E1novan\u00E1 studie v letech 1999\u20132009, celkov\u00E9 hodnocen\u00ED v\u00FDskytu VSV ve sledovan\u00E9m regionu, data vyu\u017Eita z gynekologicko-porodnick\u00FDch pracovi\u0161\u0165 a ambulanc\u00ED d\u011Btsk\u00FDch kardiologi\u00ED. Fet\u00E1ln\u00ED echokardiografie jako pl\u00E1novan\u00FD screening ve II. trimestru gravidity. Soubor z vlastn\u00EDho pracovi\u0161t\u011B, hodnocen\u00ED 22 743 t\u011Bhotenstv\u00ED. Sledov\u00E1n\u00ED a rozbor rizikov\u00FDch faktor\u016F pro vznik VSV (rizikov\u00E9 faktory matky, rodiny a plodu). Celkov\u00E9 do\u0161et\u0159en\u00ED p\u0159i z\u00E1chytu srde\u010Dn\u00ED vady (extrakardi\u00E1ln\u00ED anom\u00E1lie, genetika). Ve sledovan\u00E9m obdob\u00ED se v regionu MS kraje vyskytlo 453 v\u00FDznamn\u00FDch VSV (3,55/1000 porod\u016F). Prenat\u00E1ln\u011B identifikov\u00E1no bylo 208 VSV (45,9 %). Rizikov\u00FD faktor v anamn\u00E9ze uvedlo 15,9 % rodin. Rozd\u00EDl v\u00FDskytu VSV ve skupin\u011B s rizikov\u00FDmi faktory proti skupin\u011B bez z\u00E1t\u011B\u017Ee byl statisticky v\u00FDznamn\u00FD (\u03C72=7,28, p<0,0001). V\u011Bkov\u00E1 hranice 35 let se uk\u00E1zala pro v\u00FDskyt VSV jako nev\u00FDznamn\u00E1, celkov\u011B ale s v\u011Bkem pravd\u011Bpodobnost v\u00FDskytu VSV rostla (GLM, z=2,468, p=0,013). Prenat\u00E1ln\u00ED detekce vrozen\u00FDch srde\u010Dn\u00EDch vad m\u00E1 nejv\u011Bt\u0161\u00ED v\u00FDznam jako pl\u00E1novan\u00E9 screeningov\u00E9 vy\u0161et\u0159en\u00ED, nej\u010Dast\u011Bji ve II. trimestru gravidity. Rizikov\u00E9 faktory v anamn\u00E9ze matky zvy\u0161uj\u00ED pravd\u011Bpodobnost v\u00FDskytu VSV a rizikov\u00E9 rodin\u011B je mo\u017En\u00E9 nab\u00EDdnou vy\u0161et\u0159en\u00ED specialistou na fet\u00E1ln\u00ED echokardiografii. Srde\u010Dn\u00ED vady jsou nej\u010Dast\u011Bj\u0161\u00ED morfologick\u00E9 anom\u00E1lie v populaci a vyskytuj\u00ED se v\u011Bt\u0161inou v izolovan\u00E9 form\u011B."@cs . "\u010Cesk\u00E1 gynekologie" . "Hodnocen\u00ED v\u00FDskytu v\u00FDznamn\u00FDch vrozen\u00FDch srde\u010Dn\u00EDch vad (VSV) v regionu Moravskoslezsk\u00E9ho (MS) kraje, \u00FAsp\u011B\u0161nost jejich prenat\u00E1ln\u00ED detekce a p\u0159edstaven\u00ED fet\u00E1ln\u00ED echokardiografie jako screeningov\u00E9ho vy\u0161et\u0159en\u00ED. Zkoum\u00E1n\u00ED v\u00FDskytu rizikov\u00FDch faktor\u016F v anamn\u00E9ze a jejich vliv na vznik srde\u010Dn\u00ED vady. Pl\u00E1novan\u00E1 studie v letech 1999\u20132009, celkov\u00E9 hodnocen\u00ED v\u00FDskytu VSV ve sledovan\u00E9m regionu, data vyu\u017Eita z gynekologicko-porodnick\u00FDch pracovi\u0161\u0165 a ambulanc\u00ED d\u011Btsk\u00FDch kardiologi\u00ED. Fet\u00E1ln\u00ED echokardiografie jako pl\u00E1novan\u00FD screening ve II. trimestru gravidity. Soubor z vlastn\u00EDho pracovi\u0161t\u011B, hodnocen\u00ED 22 743 t\u011Bhotenstv\u00ED. Sledov\u00E1n\u00ED a rozbor rizikov\u00FDch faktor\u016F pro vznik VSV (rizikov\u00E9 faktory matky, rodiny a plodu). Celkov\u00E9 do\u0161et\u0159en\u00ED p\u0159i z\u00E1chytu srde\u010Dn\u00ED vady (extrakardi\u00E1ln\u00ED anom\u00E1lie, genetika). Ve sledovan\u00E9m obdob\u00ED se v regionu MS kraje vyskytlo 453 v\u00FDznamn\u00FDch VSV (3,55/1000 porod\u016F). Prenat\u00E1ln\u011B identifikov\u00E1no bylo 208 VSV (45,9 %). Rizikov\u00FD faktor v anamn\u00E9ze uvedlo 15,9 % rodin. Rozd\u00EDl v\u00FDskytu VSV ve skupin\u011B s rizikov\u00FDmi faktory proti skupin\u011B bez z\u00E1t\u011B\u017Ee byl statisticky v\u00FDznamn\u00FD (\u03C72=7,28, p<0,0001). V\u011Bkov\u00E1 hranice 35 let se uk\u00E1zala pro v\u00FDskyt VSV jako nev\u00FDznamn\u00E1, celkov\u011B ale s v\u011Bkem pravd\u011Bpodobnost v\u00FDskytu VSV rostla (GLM, z=2,468, p=0,013). Prenat\u00E1ln\u00ED detekce vrozen\u00FDch srde\u010Dn\u00EDch vad m\u00E1 nejv\u011Bt\u0161\u00ED v\u00FDznam jako pl\u00E1novan\u00E9 screeningov\u00E9 vy\u0161et\u0159en\u00ED, nej\u010Dast\u011Bji ve II. trimestru gravidity. Rizikov\u00E9 faktory v anamn\u00E9ze matky zvy\u0161uj\u00ED pravd\u011Bpodobnost v\u00FDskytu VSV a rizikov\u00E9 rodin\u011B je mo\u017En\u00E9 nab\u00EDdnou vy\u0161et\u0159en\u00ED specialistou na fet\u00E1ln\u00ED echokardiografii. Srde\u010Dn\u00ED vady jsou nej\u010Dast\u011Bj\u0161\u00ED morfologick\u00E9 anom\u00E1lie v populaci a vyskytuj\u00ED se v\u011Bt\u0161inou v izolovan\u00E9 form\u011B." . . "7"^^ . . "5" . "RIV/00843989:_____/11:00101855" . "2"^^ . . "[190BF25C7B45]" . "Rizikov\u00E9 faktory v anamn\u00E9ze t\u011Bhotn\u00FDch \u017Een p\u0159i prenat\u00E1ln\u00EDm screeningu vrozen\u00FDch srde\u010Dn\u00EDch vad" . . . . . "3"^^ . "CZ - \u010Cesk\u00E1 republika" . "1210-7832" . . "Rizikov\u00E9 faktory v anamn\u00E9ze t\u011Bhotn\u00FDch \u017Een p\u0159i prenat\u00E1ln\u00EDm screeningu vrozen\u00FDch srde\u010Dn\u00EDch vad"@cs . "I, V" . "Jab\u016Frek, L." . "227251" . "76" . "Pavl\u00ED\u010Dek, Jan" . . . "Gruszka, Tom\u00E1\u0161" . . "Evaluation of the congenital heart defects (CHDs) incidence and their prenatal detection rate in the Moravian-Silesian region. Presentation of fetal echocardiography as a screening method. Investigation of the relationship between risk factor and congenital heart defects. Long-term study between 1999\u20132009. Overall evaluation of CHDs incidence and their follow-up and analysis of their link to possible risk factors. The data were collected from medical notes of the gynecologist and pediatric cardiologist in the region. Fetal echocardiography was performed as a primary screening during the second term of pregnancy. A number of 22\u200243 pregnant women were included in the study. When any pregnancy pathology detected, more detailed examination followed (extracardial diseases, chromosomal aberrations). In the observed period, there were a total of 453 significant CHD (3.55/1000 births). In prenatal phase 208 CHDs (45.9%) were diagnosed. At least one risk factor was mentioned in 15.9 % of the screened families. When compared with the group without and with any risk factor, the difference is significant (\u03C72=7.28, p<0.0001). Mothers younger than 35 were compared with those aged 35 and older and the difference in values was not significant. However, generally, the probability of CHDs grow with age (GLM, z=2.468, p=0.013). Prenatal detection of CHDs has the highest success rate as a rutine screening method during the second trimester of pregnancy. We confirmed the existence of a higher occurrence of the CHD in the group of pregnant women with a history of risk factors in comparison with the group without such a history. The risk families should be offered a detailed examination by paediatric cardiologist skilled in fetal echocardiography. Heart defects are the most common morphology anomalies, mostly occuring as an isolated issue."@en . "Risk factors in the medical history of pregnant women undergoing congenital heart defect prenatal screening"@en . "Rizikov\u00E9 faktory v anamn\u00E9ze t\u011Bhotn\u00FDch \u017Een p\u0159i prenat\u00E1ln\u00EDm screeningu vrozen\u00FDch srde\u010Dn\u00EDch vad" . . . "Rizikov\u00E9 faktory v anamn\u00E9ze t\u011Bhotn\u00FDch \u017Een p\u0159i prenat\u00E1ln\u00EDm screeningu vrozen\u00FDch srde\u010Dn\u00EDch vad"@cs .